We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Marketing Agreement for Prion Filter

By HospiMedica staff writers
Posted on 23 Aug 2004
A strategic alliance has been announced that will focus on the marketing and further development of products for the selective adsorption of prions and viruses from blood and blood-derived products.

Pathogen Removal and Diagnostic Technologies, Inc. More...
(PRDT), a joint venture of ProMetic Life Sciences (Cambridge, UK) and the American Red Cross (Washington, DC, USA) have formed an alliance with MacoPharma (Lille, France), a large distributor of blood collection bag sets, to market the first commercially available prion filter for red blood cells.

PRDT scientists have identified lead ligands capable of specifically targeting certain types of viruses that remain a challenge to the blood industry. The company's prion-removal ligands are the only products that address the selective adsorption of infectious prion proteins, states ProMetic. The ligands were shown to be successful in preliminary studies. The product line may ultimately target a number of viruses by the onsite filtration of donor blood supplies in blood transfusion centers, in order to reduce the risk of transmission of viruses such as West Nile virus and hepatitis C.

"PRDT's technology is an innovative breakthrough for the blood industry, and our market position in Europe will be consolidated,” said Herve Dubly, president of MacoPharma.





Related Links:
Prometic
MacoPharma

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Patient Monitoring System
AlarmSense
New
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.